Satellos Bioscience (MSLE) Shares Outstanding (2024 - 2026)
Satellos Bioscience's (MSLE) quarterly Shares Outstanding (Entity) came in at $15.5 million in Q4 2025, up 125.78% year-on-year from $6.8 million in Q4 2024, and up 125.78% on a QoQ basis from $6.8 million in Q4 2024.
Satellos Bioscience (MSLE) Shares Outstanding (2024 - 2026) Analysis & Trends
Satellos Bioscience (MSLE) has 2 years of Shares Outstanding (Entity) data on file, last reported at $15.5 million in Q4 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 125.78% year-over-year to $15.5 million in Q4 2025; TTM through Dec 2025 was $15.5 million, a 125.78% increase from a year earlier, with the FY2025 full-year figure at $15.5 million, up 125.78% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $15.5 million, up from $6.8 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for MSLE reached as high as $15.5 million in Q4 2025 and fell as low as $6.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Satellos Bioscience | 148.71 Mn | 148.71 Mn | - | 18.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.44 Mn |
| Dec 31, 2025 | 14.60 Mn |
| Mar 31, 2025 | 13.82 Mn |
| Dec 31, 2024 | 9.56 Mn |